Zhen Qin

1.1k total citations
45 papers, 803 citations indexed

About

Zhen Qin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhen Qin has authored 45 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Zhen Qin's work include Extracellular vesicles in disease (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Zhen Qin is often cited by papers focused on Extracellular vesicles in disease (5 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Zhen Qin collaborates with scholars based in China, United States and New Zealand. Zhen Qin's co-authors include Wei Xu, Junnan Tang, Jun Chen, Jingfu Qiu, Jinying Zhang, Yongzheng Lu, Shuai Chen, Xiaolin Cui, Yanyan Xu and Chaorui Li and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Physical Chemistry B.

In The Last Decade

Zhen Qin

42 papers receiving 791 citations

Peers

Zhen Qin
Jiayu Sun China
Zhen Qin
Citations per year, relative to Zhen Qin Zhen Qin (= 1×) peers Jiayu Sun

Countries citing papers authored by Zhen Qin

Since Specialization
Citations

This map shows the geographic impact of Zhen Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Qin more than expected).

Fields of papers citing papers by Zhen Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Qin. The network helps show where Zhen Qin may publish in the future.

Co-authorship network of co-authors of Zhen Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Qin. A scholar is included among the top collaborators of Zhen Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Qin. Zhen Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ge, Zhen Qin, Yufeng Jiang, et al.. (2025). Targeted Delivery of Exosome-Derived miRNA-185-5p Inhibitor via Liposomes Alleviates Apoptosis and Cuproptosis in Dilated Cardiomyopathy. International Journal of Nanomedicine. Volume 20. 9407–9425. 2 indexed citations
2.
Li, You, Fengli Zhang, Zhen Qin, & Shang‐Tian Yang. (2025). Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase. Bioengineering. 12(4). 335–335.
4.
Qin, Zhen & Tao Xu. (2025). Deciphering the deterministic role of TCR signaling in T cell fate determination. Frontiers in Immunology. 16. 1562248–1562248.
5.
Qin, Zhen, et al.. (2024). Inhibition of Lck/Fyn kinase activity promotes the differentiation of induced Treg cells through AKT/mTOR pathway. International Immunopharmacology. 134. 112237–112237. 4 indexed citations
6.
Zhang, Ge, et al.. (2024). Differential Expression Spectrum of circRNA in Plasma Exosomes in Dilated Cardiomyopathy With Heart Failure. Journal of Cellular and Molecular Medicine. 28(24). e70258–e70258. 5 indexed citations
7.
Su, Chang, Zhen Qin, Yan Lv, et al.. (2024). TYG Index as a Novel Predictor of Clinical Outcomes in Advanced Chronic Heart Failure with Renal Dysfunction Patients. Clinical Interventions in Aging. Volume 19. 639–654. 2 indexed citations
8.
Zhang, Li, Ge Zhang, Yongzheng Lu, et al.. (2023). Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure. Journal of Cellular and Molecular Medicine. 27(14). 1988–2003. 19 indexed citations
9.
Hou, Yachen, Xiaolin Cui, Zhen Qin, et al.. (2023). Three-dimensional bioprinting of artificial blood vessel: Process, bioinks, and challenges. International Journal of Bioprinting. 9(4). 740–740. 22 indexed citations
10.
Li, Demin, Ge Zhang, Zeyu Wang, et al.. (2023). Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. European Journal of Pharmacology. 943. 175569–175569. 48 indexed citations
11.
Qin, Zhen, Ruixia Yuan, Jiacheng Guo, et al.. (2022). Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction. ESC Heart Failure. 10(1). 478–491. 25 indexed citations
12.
Lu, Yongzheng, Xiaolin Cui, Li Zhang, et al.. (2022). The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging and Disease. 13(2). 491–491. 61 indexed citations
13.
Lu, Yongzheng, Zeyu Wang, Jiacheng Guo, et al.. (2022). Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics. Aging and Disease. 14(4). 0–0. 15 indexed citations
14.
Qin, Zhen, Xiaolin Cui, Li Zhang, et al.. (2022). The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus. Frontiers in Cardiovascular Medicine. 9. 992252–992252. 14 indexed citations
15.
He, Dong, Tao Xin, Bo Pang, et al.. (2022). A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy. Journal of Experimental & Clinical Cancer Research. 41(1). 349–349. 23 indexed citations
16.
Tang, Junnan, Xiaolin Cui, Zenglei Zhang, et al.. (2021). Injection‐Free Delivery of MSC‐Derived Extracellular Vesicles for Myocardial Infarction Therapeutics. Advanced Healthcare Materials. 11(5). e2100312–e2100312. 64 indexed citations
17.
Guo, Jiacheng, Yongzheng Lu, Chang Cao, et al.. (2021). An antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair. Bioactive Materials. 10. 56–67. 23 indexed citations
18.
Guo, Jiacheng, Xu Wang, Yanyan Xu, et al.. (2021). Advances in Nanomaterials for Injured Heart Repair. Frontiers in Bioengineering and Biotechnology. 9. 686684–686684. 4 indexed citations
19.
Fu, Li, Jingrong Li, Juan Zhang, et al.. (2020). CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy. Acta Pharmacologica Sinica. 42(1). 142–148. 8 indexed citations
20.
Chen, Daiwen, et al.. (2018). A voltammetric immunosensor for clenbuterol based on the use of a MoS2-AuPt nanocomposite. Microchimica Acta. 185(4). 209–209. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026